Literature DB >> 14741439

Immune cell activity during the initial stages of withdrawal from chronic exposure to cocaine or morphine.

Albert H Avila1, Norma C Alonzo, Barbara M Bayer.   

Abstract

The immunosuppression accompanying illicit drug use has been shown to contribute to a decreased resistance to a variety of pathogens; however, there is relatively little information on how long these effects persist following withdrawal from chronic drug exposure. To begin to address this question, Sprague-Dawley male rats were administered either cocaine (10 mg/kg, i.p., b.i.d.) for 7 days or morphine (escalating doses up to 40 mg/kg, s.c., b.i.d.) for a 10-day period. Control groups of animals received similar saline injections for equivalent time periods. Drug administration was abruptly discontinued and animals were sacrificed at 2, 24, 72 or 96 h following the last dose. At these time points, proliferation responses of peripheral blood T-lymphocytes stimulated by concanavalin A (Con A) and plasma levels of corticosterone were measured. Plasma corticosterone levels of cocaine- or morphine-treated animals were found to be significantly elevated 24 h following drug cessation as compared to saline animals. At this time, proliferation responses were significantly decreased and were further suppressed during cocaine and morphine withdrawal at 96 and 72 h, respectively. These results suggest that abrupt cessation of cocaine or morphine administration leads to activation of stress-related pathways that may contribute to an increased susceptibility of infection during the initial withdrawal phase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14741439     DOI: 10.1016/j.jneuroim.2003.10.023

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

1.  Increased sensitivity to Salmonella enterica serovar Typhimurium infection in mice undergoing withdrawal from morphine is associated with suppression of interleukin-12.

Authors:  Pu Feng; Qiana M Wilson; Joseph J Meissler; Martin W Adler; Toby K Eisenstein
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Morphine suppresses MHC-II expression on circulating B lymphocytes via activation of the HPA.

Authors:  Alexandria L Nugent; Richard A Houghtling; Barbara M Bayer
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-04       Impact factor: 4.147

Review 3.  Systems-level view of cocaine addiction: the interconnection of the immune and nervous systems.

Authors:  Christina C Marasco; Cody R Goodwin; Danny G Winder; Nicole L Schramm-Sapyta; John A McLean; John P Wikswo
Journal:  Exp Biol Med (Maywood)       Date:  2014-06-05

4.  Essential role of toll-like receptor 2 in morphine-induced microglia activation in mice.

Authors:  Yi Zhang; Hui Li; Yi Li; Xiuli Sun; Mengyang Zhu; Gregory Hanley; Gene Lesage; Deling Yin
Journal:  Neurosci Lett       Date:  2010-12-02       Impact factor: 3.046

Review 5.  Intensive Care Unit-acquired infection as a side effect of sedation.

Authors:  Saad Nseir; Demosthenes Makris; Daniel Mathieu; Alain Durocher; Charles-Hugo Marquette
Journal:  Crit Care       Date:  2010-03-15       Impact factor: 9.097

Review 6.  Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system.

Authors:  Thomas J Connor
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

7.  Morphine withdrawal dramatically reduces lymphocytes in morphine-dependent macaques.

Authors:  Michael R Weed; Lucy M Carruth; Robert J Adams; Nancy A Ator; Robert D Hienz
Journal:  J Neuroimmune Pharmacol       Date:  2006-07-14       Impact factor: 4.147

8.  Enhanced immune sensitivity to stress following chronic morphine exposure.

Authors:  Kimberly A Ballard; Trisha C Pellegrino; Norma C Alonzo; Alexandria L Nugent; Barbara M Bayer
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 7.285

9.  Remifentanil discontinuation and subsequent intensive care unit-acquired infection: a cohort study.

Authors:  Saad Nseir; Jérémy Hoel; Guillaume Grailles; Aude Soury-Lavergne; Christophe Di Pompeo; Daniel Mathieu; Alain Durocher
Journal:  Crit Care       Date:  2009-04-21       Impact factor: 9.097

10.  A review on hematological factors in opioid-dependent people (opium and heroin) after the withdrawal period.

Authors:  Tahereh Haghpanah; Mohammadreza Afarinesh; Kouros Divsalar
Journal:  Addict Health       Date:  2010 Winter-Spring
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.